Ignite Creation Date:
2025-12-24 @ 7:59 PM
Ignite Modification Date:
2025-12-25 @ 5:33 PM
Study NCT ID:
NCT04582604
Status:
UNKNOWN
Last Update Posted:
2020-10-20
First Post:
2020-10-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Ruxolitinib and Decitabine for High Risk Hematological Malignancies
Sponsor:
Chinese PLA General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-10-03
First Submit QC Date:
None
Study First Post Date:
2020-10-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-19
Last Update Post Date:
2020-10-20
Last Update Post Date Type:
ACTUAL